Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Cancer Cell|January 12, 2024
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Adam J Schoenfeld, Darwin Ye, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Cancer Cell|March 31, 2023
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockadeJoy A Pai, Matthew D Hellmann, Jennifer L Sauter, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Nature|January 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerMasataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
Cell|October 2, 2020
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y Nabet, Mohammad S Esfahani, Everett J Moding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal CancerNeil H Segal, Andrea Cercek, Geoffrey Ku, et al.
The New England Journal of Medicine|April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.
Science (New York, N.Y.)|March 5, 2016
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Cancer Cell|January 12, 2024
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Adam J Schoenfeld, Darwin Ye, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Cancer Cell|March 31, 2023
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockadeJoy A Pai, Matthew D Hellmann, Jennifer L Sauter, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Nature|January 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerMasataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
Cell|October 2, 2020
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y Nabet, Mohammad S Esfahani, Everett J Moding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal CancerNeil H Segal, Andrea Cercek, Geoffrey Ku, et al.
The New England Journal of Medicine|April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.
Science (New York, N.Y.)|March 5, 2016
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, et al.
Pageof 22